← Back

Cambridge Innovation Capital

Europe HQ Seed Series-A
Cheque range
(undisclosed)
Stages
Seed, Series A
Avg deals / year
–
Leads rounds
Yes
HQ
Cambridge
Fund type
Venture fund

01 · Thesis & focus

Cambridge-based fund managing over £500M, one of the most active Series A deeptech and life sciences investors in the Cambridge ecosystem (Pragmatic, Riverlane, Gyroscope); launched a £100M Opportunity Fund in 2025 backed by Aviva and British Patient Capital. A major established UK deeptech Series A lead.

Sectors (3)

02 · Recent publicly announced deals

T-Therapeutics Ltd Series B · Nov 2026 site ↗
Microbiotica Series C · Oct 2026 site ↗

Microbiotica develops defined live bacterial therapeutics for immuno-oncology and inflammatory bowel disease, using a clinic-led discovery platform to identify bacteria associated with patient outcomes and select relevant patient populations. Its methods include gut bacterial culturing, microbiome analysis, reference genome databases, bioinformatics, and microbiome–host biology research.

Salience Labs 🇬🇧 Series B · Oct 2026 · $125M announcement ↗ site ↗

All-optical switches connecting GPUs across racks in AI data centers

Founders: Johannes F., Vaysh K., Wolfram P., Harish B.
CMR Surgical 🇬🇧 Round · Oct 2026 site ↗

CMR Surgical develops a modular, portable robotic system for minimally invasive surgery, designed to fit into existing operating rooms and support familiar laparoscopic port placement and workflows. Its offering also includes a digital ecosystem that provides data and insights related to surgical care and operational efficiency.

03 · Similar firms

Raising? See which European funds fit your round →